ERBB2 and neoplasm: Ishikawa et al. reported that in 60% of the samples from a Japanese cohort of patients with HER2 negative breast cancer (biopsy samples), platelets were found directly surrounding the primary tumor cells, and that these tumor cells showed the expression of EMT markers [217].